Searched for
URINARY INCONTINENCE
Johnson & Johnson prostate cancer drug reduces risk of cancer spread and death in late-stage studyThe study, which followed patients for over five years, found that those who received the regimen were nine times more likely to have lit...- ‘Doing what I do best’: Namita Thapar shares new reel amid controversyEmcure Pharmaceuticals' Namita Thapar shared a health awareness video amid controversy over her namaz remarks. Meanwhile, Lenskart faced ba...
- Zydus Lifesciences shares in focus after Ahmedabad oncology unit gets USFDA EIRZydus Lifesciences got a USFDA clearance upgrade for its Ahmedabad oncology plant, moving from OAI to VAI status after a June inspection—a ...
- Zydus Lifesciences shares in focus on USFDA nod for canine drugShares of Zydus Lifesciences are likely in focus after its subsidiary, ZyVet Animal Health, launched the first FDA-approved generic treatme...
- Billy Joel diagnosis: What is Normal Pressure Hydrocephalus, and how is it related to dementia? Symptoms and treatmentMusic legend Billy Joel, 76, has been diagnosed with normal pressure hydrocephalus (NPH), a neurological condition often mistaken for demen...
- Zydus Lifesciences launches generic drug for overactive bladder in US marketZydus is among the first suppliers to launch the generic version of Mirabegron extended-release tablets (USP 25 mg) in the US market. The c...
- Zydus Lifesciences rises 4% on getting approval from USFDA for Mirabegron Tablets“Zydus was one of the first ANDA applicants to submit a substantially complete ANDA with a paragraph IV certification for Mirabegron Extend...
- Alembic Pharma gets tentative USFDA nod for fesoterodine fumarate extended-release tabletsThe approval by the US Food & Drug Administration (USFDA) for the abbreviated new drug application (ANDA) for fesoterodine fumarate extende...
- Do you experience urinary bladder problems? Here's how you can diagnose and cureUrine storage and emptying is complex coordination between bladder and urethra, and disturbances in the system can lead to a urinary proble...
- Strides gets USFDA nod for generic Oxybutynin Chloride tabletsCompany's step-down wholly owned subsidiary Strides Pharma Global Pte Ltd, Singapore, has received approval for Oxybutynin Chloride Tablets...
- Zydus Cadila gets USFDA nod for overactive bladder treatment drugThe company has received final approval from the United States Food and Drug Administration (USFDA) to market Solifenacin Succinate tablets...
- Granules India gets USFDA nod for overactive bladder treatment capsule"The US Food and Drug Administration (USFDA) has approved the abbreviated new drug application filed by Granules Pharmaceuticals, Inc, a wh...
- Zydus Cadila gets tentative USFDA nod for overactive bladder treatment drugThe product will be manufactured at the group's manufacturing facility at SEZ in Ahmedabad.
- Alembic Pharmaceuticals gets USFDA go-ahead for bladder drugAccording to IMS December 2016 data, Darifenacin extended release tablets had an estimated market size of USD 64 million.
- Zydus Cadila gets USFDA nod for two drugsThe group has also received the tentative approval for Solifenacin Succinate tablets in strengths of 5 mg and 10 mg, Zydus Cadila said.
- USFDA gives nod to Zydus Cadila's overactive bladder tabletsThe drug is used to take care of an overactive bladder and urinary incontinence and will be produced at the group's formulation manufacturi...
- Jubilant Life gets USFDA nod for urinary incontinence drugThe company has "received Abbreviated New Drug Application (ANDA) final approval for Darifenacin Extended-Release Tablets, 7.5 mg and 15 mg.
- Cipla gets USFDA nod for overactive bladder treating drug"We have received final approval for ANDA for Darifenacin extended-release tablets, 7.5 mg and 15mg, from USFDA," a company statement said ...
- Rare surgery performed on five-year-old girlA five-year-old girl underwent a rare surgery by which "extra flesh" found in the backbone was removed at the Government Rajaji Hospital in...
- Elder Pharma to market Cymbiotics drugs in IndiaThe California-based bio-pharmaceutical company, Cymbiotics, has signed an in-licensing deal with Elder Pharmaceuticals to market six of it...
Load More
